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Abstract 
We tested the hypothesis that increasing the nitric oxide (NO) bioavailability by dietary 
nitrate would recover the hypoxic-induced reduction in dynamic CA. Twelve healthy 
males (age 21 ± 2 years) completed four days of dietary supplementation with a placebo 
or inorganic nitrate drink (140-ml beetroot juice) followed by 60-min of normoxia or 
hypoxia (fraction of inspired oxygen [FiO2] = 13%). Duplex ultrasonography was used 
to perform volumetric change-based assessment of dynamic CA in the internal carotid 
artery (ICA). Dynamic CA was assessed by rate of regulation (RoR) of vascular 
conductance using the thigh-cuff method. Four days of beetroot supplementation 
increased circulating nitrate by 208 [171,245] M (mean difference [95% confidence 
interval]) compared with placebo. Dynamic CA was lower in hypoxia than normoxia 
(RoR Δ-0.085 [-0.116, -0.054]). Compared with placebo, nitrate did not alter dynamic 
CA in normoxia (RoR Δ-0.022 [-0.060, 0.016]) or hypoxia (RoR Δ0.017 [-0.019, 
0.053]). Further, nitrate did not affect ICA vessel diameter, blood velocity or flow in 
either normoxia or hypoxia. Increased bioavailability of NO through dietary nitrate 
supplementation did not recover the hypoxia-induced reduction in dynamic CA. This 
suggests the mechanism of hypoxia-induced reduction in dynamic CA does not relate to 
the availability of NO. 
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INTRODUCTION 
Cerebral autoregulation (CA) is essential to protect the brain against ischaemic injury, 
capillary damage, and edema1,2. Dynamic CA is the maintenance of cerebral blood flow 
(CBF) at constant levels despite acute changes in cerebral perfusion pressure or in 
systemic blood pressure3. The physiological mechanisms responsible for the control of 
dynamic cerebral autoregulation are thought to involve a combination of nitric oxide 
(NO), neurogenic (sympathetic and cholinergic) and myogenic (stretching vascular 
smooth muscle) factors1. While dynamic CA normally ensures the preservation of CBF, 
including to transient hypertension4,5, studies demonstrate that dynamic CA is reduced 
during transient hypotension in normoxic and hypoxic conditions (i.e. acute hypoxia 
and at high altitude)4-14. The impairment in dynamic CA is characterized by a blunted 
increase in cerebrovascular conductance (CVC) in response to systemic hypotension, 
preventing normalization of CBF13. The mechanism by which hypoxia reduces dynamic 
CA is unclear but may relate to nitric oxide (NO) availability15. 
 
NO is a potent vasodilator and plays a vital role in the regulation of CVC, and 
consequently CBF16. Previous research in humans, breathing normal ambient air, has 
shown dynamic CA to be substantially reduced when the enzyme NO synthase is 
inhibited15. In oxygen-depleted environments, the L-arginine pathway, which is helped 
by the enzyme NO-synthase, has a decreased ability to generate NO17. NO can also be 
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generated by the serial reduction of nitrate (NO3
-) to nitrite (NO2
-) and then NO, 
providing an alternative pathway for NO production in hypoxia18,19. Dietary nitrate 
supplementation has been shown to be effective to increase the NO bioavailability20, 
and improve cerebral regulation and CBF in normoxia21,22. Specifically, dietary nitrate 
supplementation has previously been shown to enhance cerebral perfusion21 and 
increase middle cerebral artery blood flow velocity via a reduction in cerebrovascular 
resistance22. In addition, dietary nitrate has been shown to reverse the hypoxia-induced 
impairment in peripheral NO-dependent endothelial function23. Combined, this suggests 
dietary nitrate may be effective to reverse the hypoxia-induced impairment in dynamic 
CA. 
 
The aim of this study was to determine the role of NO availability in the hypoxia-
induced reduction of dynamic CA. We hypothesized nitrate supplementation would 
reverse the hypoxia-induced reduction in dynamic CA, which would provide evidence 
that NO plays a central role in the mechanism of hypoxia-induced reduction in dynamic 
CA.  
 
METHODS 
Participants  
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All procedures were approved by the ethical committee of Mt. Fuji Reseach Institute 
and were performed in accordance with the guidelines of the Declaration of Helsinki 
(ECMFRI-01-2014). After a detailed explanation of all study procedures, including the 
possible risks and benefits of participation, each participant gave his written consent. 
Twelve healthy male participants with a mean age of 21 ± 2 years, 174 ± 5 cm, and 
body mass 69 ± 8 kg (mean ± standard deviation [SD]) were enrolled. They were free 
from any cardiovascular or cerebrovascular diseases, and were not taking any 
medications. Participants engaged in regular recreational sports (1-2 h per day, 2-4 days 
per week). None of the participants was exposed to an altitude higher than 1500 m 
within 6 months before the study. In addition, participants were asked to abstain from 
caffeine for 12 h and from strenous exercise and alcohol for at least 24 h before the 
study. Participants were familiarized with measurement techniques (i.e., thigh-cuff 
testing for dynamic CA and measurement of blood flow in the intrnal carotid artery 
[ICA]). All studies were performed in an environmental chamber (TBR-4, 5SA2GX, 
Tabai Espec Co, Ltd., Tokyo, Japan) with set at an ambient temperature of 24°C and at 
relative himidity of 40%. 
  
Study design 
The study followed a double-blinded placebo-controlled crossover design. All 
participants performed two trials, each assessing dynamic CA in both normoxia and 
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hypoxia after four days of (1) nitrate-rich beetroot juice (nitrate) and (2) nitrate-depleted 
beetroot juice (placebo) dietary supplementation. These two trials were performed with 
at least a 2-week washout period and in random order. An overview of the study 
protocol is shown in Figure 1. 
 
Supplementation 
For the three days before the trials, participants consumed 140 ml per day of NO3
--rich 
beetroot juice (nitrate; Beet It, James White Drinks, Ltd., Ipswich, UK) or 140 mL per 
day of NO3
--depleted beetroot concentrate (placebo; James White Drinks, Ltd., Ipswich, 
UK). Both participants and researchers were blinded to the drink contents until the 
completion of the study. Participants were also provided a list of foods rich in NO3
-, and 
instructed to avoid the consumption of these foods and to otherwise maintain their 
normal dietary intake for the duration of the study. In addition, they were asked to 
abstain from the use of antibacterial mouthwash for the duration of the study, as it 
eliminates the oral bacteria that reduce NO3
- to NO2
- 24.  
 
Study procedures 
On each study day (nitrate or placebo), participants consumed their final dose of nitrate 
or placebo on arrival to the laboratory, about 1.5 h before the first dynamic CA test. 
After a 30 min supine and 45 min semi-recumbent rest on a manually inclined bed 
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(A4524-0096L, Paramount Bed Co., Ltd., Tokyo, Japan), a venous blood sample (10 
mL) was collected from the antecubital vein into a vacutainer and immediately 
centrifuged at 1000 g for 15 min at 4°C (Kubota 5200, Kubota Co., Ltd., Tokyo, Japan) 
to separate serum from whole blood. The serum samples were frozen at -80°C for 
further analysis of NO3
- content by SRL Co., Ltd. (Tokyo, Japan). Briefly, after 
deproteinizaation, serum NO3
- was measured by using high-performance liquid 
chromatography25.  After attachment of all devices, normoxic baseline values were 
measured for 5 min; then, dynamic CA assessment in normoxia was performed. 
Thereafter, hypoxic gas (FiO2 0.13) was supplied via a commercial tent (about 5000 L) 
with a hypoxic gas generating system (Hypoxico Everest Summit 2: Will Co., Ltd., 
Tokyo, Japan). Hypoxic baseline values were measured during the last 5 min of the 60-
min resting hypoxic exposure. Next, dynamic CA assessment in hypoxia was 
performed. Inspired oxygen concentration was verified before and after each experiment 
using a metabolic cart (AE-310s; Minato Medical Science, Osaka, Japan).  
 
Dynamic CA assessmemt 
Dynamic CA was assessed with participants sat on a comfortable chair in a semi-
recumbent position. After 2 min of baseline data in normoxia were recorded, bilateral 
thigh-cuffs (width 22 cm) were inflated to a pressure of 220 mmHg for 3 min using a 
custom cuff inflator. To evaluate dynamic CA, the cuff was then rapidly deflated, 
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causing a transient drop in arterial blood pressure, and measurements were continued 
for an additional minute. Participants were instructed to remain relaxed and were not 
given feedback regarding the elasped time during cuff occlusion. This protocol was 
repeated two or three times at 5-min intervals to allow for recovery to the resting 
value26. If the first or second trial reduction in mean arterial pressure (MAP) was < 15 
mmHg27, a third trial was performed, and the average value of two trials was used13. 
 
Measurements 
Right ICA measurements were performed 1.0–1.5 cm distal to the carotid bifurcation 
with a Doppler ultrasound set at 10.0 MHz and a linear transducer (Logic-e; GE 
Healthcare, Tokyo, Japan). For baseline ICA flow measurement, the ICA blood flow 
was averaged over 2 min during the last 5 min of the initial 30-min resting exposure. 
For the dynamic ICA blood flow measurements, blood flow was continuously measured 
during the thigh cuff test. To calculate the average ICA blood flow, we analyzed the 
mean vessel diameter (Dmean) and flow velocity as described in a previous study
28. 
Briefly, after obtaining a clear image of the vessel using the brightness mode, the mean 
vessel diameter was calculated as: mean diameter = (systolic diameter × 1/3) + 
(diastolic diameter × 2/3). The time-averaged mean flow velocity obained using the 
pulse wave mode was defined as the mean blood flow velocity (Vmean; in centimeters 
per second). Blood flow was calculated by multiplying the cross-sectional area × 60 (in 
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milliliters per minute). Throughout the measurement, care was taken to ensure that the 
probe position was stable, the insonation angle did not vary (< 60° in all cases) and the 
sample volume was positioned in the center of the vessel and adjusted to cover the 
width of the vessel diameter. Heart rate (HR) was monitored using three-lead ECG. 
Pulmonary ventilation (V
．
E) and partial pressure of end-tidal carbon dioxide output 
(PETCO2) were measured by a breath-by-breath gas analyzer (AE-310S; Minato Medical 
Science, Osaka, Japan). Standard gases (O2 15.23%, CO2 4.999%, and N2 balance) and 
room air were used to calibrate the gas analyzer before each test. Beat-by-beat MAP 
was measured using finger photoplethysmography from the middle or index finger of 
the left hand (MUB-101; Medi-sens, Saiatama, Japan). Peripheral arterial oxygen 
saturation (SpO2) was monitored by finger pulse oximetry (PULFIS WB-100, Japan 
Precision Instruments Inc., Gunma, Japan). 
 
Data analysis 
We calculated the rate of regulation (RoR) as an indicator of dynamic CA29. For 
calculation of RoR, baseline values for MAP, ICA blood flow and cerebrovascular  
conductance (ICA/MAP) were defined as the mean during the 4 s immediately before 
the thigh-cuff release. The RoR was calculated from the slope of the regression line 
between ICA conductance and the time from 1.0 to 4.0 s after thigh-cuff deflation and 
normalized to the degree of cuff-release-induced hypotension. The RoR = (ΔICA 
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conductance/Δt)/ΔMAP, where ΔICA conductance/Δt is the slope of the linear 
regression between ICA conductance and time (t), and ΔMAP is the magnitude of the 
blood pressure step, which was calculated by subtracting the baseline MAP from the 
MAP averaged during the interval from 1.0 to 4.0 s. In a previous study, the data from 
1.0 to 3.5 s after cuff deflation were used to calculate dynamic CA29; however, we 
extended this time to 4.0 s after cuff deflation to ensure beat-by-beat blood flow data for 
at least three cardiac cycles13,28. Trials in which the reduction in MAP was < 15 mmHg 
were excluded from analysis, and the average of two trials was used. The coefficient of 
variation of this measure is 13%.  
 
Statistics  
Values are expressed as means ± SD unless otherwise stated. Two-way repeated-
measures ANOVAs (oxygen × supplement) were used for comparisons of 
cardiorespiratory, hemodynamic and dynamic CA variables across conditions. P values 
< 0.05 were considered to indicate statistical significance. The magnitude of effect of 
nitrate supplementation on the hypoxia-induced decline in dynamic CA variables was 
determined by ANCOVA comparison of nitrate and placebo hypoxia trials (with 
normoxia placebo as the covariate), and interpreted in relation to a priori meaningful 
differences30. A sample size estimation for the primary analysis indicated that 10 
participants were needed to produce an 80% chance of obtaining statistical significance 
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at the 0.05 level for a two-tailed design, based on a minimum important difference of 
0.076 RoR, a standard deviation of the difference of 0.05, and an estimated correlation 
of 0.411. Statistical analyses were performed using commercial software packages 
(Sigma Stat 3.5, Hulinks, Chicago, IL, USA; SPSS V25, IBM Corp, Armonk; NY). 
 
RESULTS 
Serum nitrate 
Four days inorganic nitrate supplementation increased serum NO3
- concentrations 
compared to placebo (mean difference [95% confidence interval]: Δ208 [171, 245] M; 
P < 0.001). 
 
Cardiorespiratory and hemodynamic responses at rest 
Effect of hypoxia. Compared to normoxia, acute hypoxia decreased SpO2, and 
increased HR, ICA diameter, ICA blood flow, and CVC (all P < 0.05; Table 1). Further, 
acute hypoxia tended to increase V
．
E (P = 0.06) and decrease PETCO2 (P = 0.09). 
Hypoxia did not alter MAP or ICA blood flow velocity at rest (P > 0.05; Table 1). 
Effect of nitrate. Dietary nitrate supplementation did not affect any of the resting 
cardiovascular or cerebrovascular responses in either normoxia or hypoxia (all P > 0.05; 
Table 1). 
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Dynamic cerebral autoregulation 
Effect of hypoxia. Thigh-cuff release elicited similar MAP reductions in hypoxia and 
normoxia (P = 0.7; Table 2). In contrast, the ICA blood flow nadir in response to thigh-
cuff was greater in hypoxia than normoxia (P < 0.001; Table 2). Dynamic CA 
assessment (1-4 s after deflation) indicated that hypoxia did not alter the ΔMAP, but 
did decrease the slope of CVC (P < 0.05; Table 2). Consequently, RoR was decreased 
in hypoxia compared to normoxia (Δ-0.085 [-0.116, -0.054]; P < 0.05; Figure 3). 
Effect of nitrate. Thigh-cuff release elicited similar reductions in MAP and ICA flow 
after nitrate and placebo in normoxia and hypoxia (Table 2; interactions P > 0.9). 
During dynamic CA assessment (1-4s after deflation), nitrate had no effect on any 
dynamic CA variable in normoxia or hypoxia when compared to the placebo (Table 2, 
Figures 2 and 3). Specifically, compared to placebo, nitrate supplementation did not 
alter RoR in normoxia (Δ-0.022 [-0.060, 0.016]; P = 0.2) or hypoxia (Δ0.017 [-0.019, 
0.053]; P = 0.3). Further, compared to placebo, nitrate supplementation did not effect 
the hypoxia-induced decline in dynamic CA variables (Figure 2): MAP (Δ-0.06 [-3.62, 
3.50]; P = 0.9), ICA flow (Δ-1 [-26, 23]; P = 0.9), CVC (Δ-0.003 [-0.009, 0.002]; P = 
0.2), or RoR (Δ0.020 [-0.010, 0.051]; P = 0.2 
 
DISCUSSION 
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This study is the first to investigate the effects of dietary nitrate supplementation on 
dynamic CA in hypoxia. The major findings of this study are therefore that increased 
bioavailability of NO by dietary nitrate supplementation did not influence dynamic CA 
in acute hypoxia or recover the hypoxia-induced reduction in dynamic CA (Figure 3). In 
addition, we also show that dietary nitrate supplementation did not influence 
cerebrovascular responses, including dynamic CA, whilst participants breathed normal 
ambient air (normoxia). A particular strength of this study was the method used to 
determine dynamic CA, i.e. duplex Doppler ultrasound in conjunction with the 
traditional thigh-cuff test. In brief, we used duplex Doppler ultrasound as it enables the 
assessment of blood flow velocity and vessel diameter, which contrasts the easier-to-
perform and more commonly used TCD method that only assesses blood flow velocity. 
Previous research has shown the thigh-cuff method, which imposes a large and abrupt 
change in blood pressure, is more sensitive to interventions, such as hypoxia, than 
transfer function analysis that examines spontaneous fluctuations in blood pressure26. 
The importance of using these methods is emphasised when considering the only other 
study to have examined dietary nitrate supplementation on dynamic CA in normoxia 
reported inconclusive effects31 that may have resulted from using TCD in conjunction 
transfer function analysis, which is a less sensitive method to assess dynamic CA than 
used in the present study.   
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In our study, acute hypoxia reduced dynamic CA which is a consistent finding with many 
other studies6-14. Indeed, 10 of 12 participants had reduced dynamic CA with hypoxia 
irrespective of supplementation. However, in contrast with our hypothesis, and previous 
research that suggests NO may have an important role in regulating brain vascular tone32 
and dynamic CA15, dietary nitrate supplementation did not influence any physiological 
determinant of dynamic CA (Figure 2), or dynamic CA (Figure 3), differently than the 
placebo in acute hypoxia. Indeed, the mean difference in RoR between nitrate and placebo 
and the 95% confidence intervals indicate any effect of nitrate is trivial in magnitude. 
This finding suggests NO bioavailability has limited influence on the hypoxia-induced 
reduction in dynamic CA observed in young healthy adults. Of note, our results do not 
discount the role of NO in CBF responses including dynamic CA in hypoxia. CBF 
regulation is a complex, multifaceted physiological process, of which the action of NO is 
a key component33. The data from this study simply suggest that insufficient 
bioavailability of NO is not the primary cause of hypoxia-induced reduction in dynamic 
CA. 
A possible alternative mechanism for the hypoxia-induced reduction in dynamic 
CA could be attributed to increased vasodilation at rest29. Hypoxia is a potent 
vasodilator34, and therefore cerebral blood vessels may already be close to maximally 
dilated in hypoxia, limiting capacity for further vasodilation to maintain CVC during 
dynamic CA. In our study hypoxia substantially increased ICA diameter at rest (Table 
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1), which may have limited the capacity for further dilation in dynamic CA response to 
the thigh cuff release. Regions with already elevated CBF at rest in hypoxia have been 
previously shown to minimally increase CBF with experimental manipulations known 
to cause vasodilation35, supporting the idea that baseline diameter influences capacity 
for further dilation. Indeed, previous research supports that dynamic CA depends on 
basal vascular tone, and that the autoregulatory response in middle cerebral artery blood 
flow velocity is slower when cerebral vessels are already dilated29. Similarly, lower 
cerebrovascular resistance (higher cerebrovascular conductance) resulted in higher 
transfer function gain, indicating that dynamic CA is reduced when cerebral vessels are 
dilated36. Other factors, including prostaglandins37-40, and sympathetic nerve 
activity33,41, have been shown to contribute the regulation of CBF and may also be 
responsible for the hypoxia-induced reduction in dynamic CA.  
 
Limitations and perspectives 
Our findings should be considered carefully within the context they were obtained. To 
assess dynamic CA we measured changes in ICA blood vessel diameter and blood 
velocity flow. Global CBF however consists of ~75% ICA flow and ~25% vertebral 
artery (VA) flow42 so, although technically challenging, a more complete assessment of 
CA would have included both ICA and VA. Further, as one previous magnetic 
resonance imaging study observed regional but not global CBF differences after nitrate 
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supplementation21, future studies examining the influence of dietary nitrate on regional 
extra- and intracranial cerebral blood flow and autoregulation are warranted. Dietary 
nitrate supplementation has been shown to be effective to recover peripheral vascular 
function at high altitude23. In contrast, dietary nitrate did not affect cerebral vascular 
function during hypoxic exposure in the present study. This heterogenous response 
between vascular beds is consistent with a previous study where dietary nitrate 
increased muscle oxygenation in hypoxia, but did not affect cerebral oxygenation43. In 
combination these findings provide evidence dietary nitrate and NO influence 
peripheral and cerebral vascular responses to hypoxia by different mechanisms. The 
limited effects of dietary nitrate observed on dynamic CA in this study may be a 
consequence of the young healthy population recruited. Indeed, as other studies in 
young healthy individuals we report no effect of dietary nitrate on resting physiological 
responses in normoxia or hypoxia23,44,45. Whether dietary nitrate influences 
cerebrovascular responses and dynamic CA in persons with reduced vascular function, 
poor NO bioavailability, or clinical populations with cerebrovascular disease remains to 
be investigated. Future research should also resolve whether reductions in dynamic CA 
are related to an increase in adverse outcomes such as headache and Acute Mountain 
Sickness, which are common in hypoxic conditions7,9,13,46. Resolving this is important 
as dynamic CA could be a useful screening-tool to identify those persons at risk of 
hypoxia-induced adverse events. 
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CONCLUSION 
In conclusion, a four-day dietary inorganic nitrate supplementation did not affect resting 
cerebrovascular responses or dynamic CA in either normoxia or hypoxia (after 60-min 
exposure with 13% O2) in healthy men. This suggests NO availability is not responsible 
for hypoxia-induced reduction in dynamic CA.  
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Figure Legends 
Figure 1. The protocol of the present study. BL, baseline; dCA, dynamic cerebral 
autoregulation assessment; FiO2, fraction of inspired oxygen. 
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Figure 2. Comparisons in the components of dynamic cerebral autoregulation 
among the four conditions. The supplement contrast is defined by dashed (placebo) 
versus solid (nitrate) lines, the oxygen contrast is defined by black (normoxia) versus grey 
(hypoxia) lines. As such, the four conditions are represented as follows: placebo 
normoxia, dashed black line; nitrate normoxia, solid black line; placebo hypoxia, dashed 
grey line; nitrate hypoxia, solid grey line. All values are presented as changes from 
baseline to cuff release, normalised to baseline in each condition. Hypoxia (A) had no 
effect on mean arterial pressure (MAP), (B) decreased internal carotid artery (ICA) flow, 
and (C) decreased cerebrovascular conductance (CVC) following thigh cuff release 
(*P<0.05). However, nitrate had no effect on (A) MAP, (B) ICA flow, or (C) CVC (all 
P>0.05). Values are means ± SD. *P < 0.05 between normoxia and hypoxia. 
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Figure 3. Dynamic cerebral autoregulation (rate of regulation: RoR) in normoxia 
and hypoxia after placebo and nitrate supplementation. * Significant difference 
between normoxia and hypoxia (P > 0.05). Values are means ± standard deviation (SD). 
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Table 1. Resting cardiorespiratory and hemodynamic responses in normoxia and hypoxia after placebo and nitrate supplementation. 
 Placebo Nitrate Two-way ANOVA 
 Normoxia Hypoxia Normoxia Hypoxia Suppl. Oxygen Interaction 
Cardiorespiratory  
V
．
E, l min-1 10.0 ± 1.4 10.6 ± 1.4 10.2 ± 0.9 10.6 ± 1.7 0.678 0.059 0.784 
PETCO2, mmHg 37.8 ± 1.9 36.5 ± 1.9 37.7 ± 2.1 36.5 ± 1.7 0.852 0.094 0.903 
HR, bpm 63 ± 5 68 ± 5* 64 ± 5 69 ± 4* 0.137 <0.001 0.828 
MAP, mmHg 83 ± 5 85 ± 6 84 ± 5 85 ± 5 0.342 0.133 0.712 
SpO2, % 98.2 ± 0.5 85.2 ± 4.8* 98.4 ± 0.8 85.9 ± 4.0* 0.160 <0.001 0.442 
Internal carotid artery   
Blood flow, ml min-1 327 ± 20 345 ± 26* 337 ± 21 356 ± 36* 0.274 0.022 0.880 
Blood velocity, cm s-1 29.0 ± 5.3 26.4 ± 2.5 27.9 ± 4.9 26.2 ± 3.5 0.555 0.149 0.655 
Diameter, cm 0.49 ± 0.05 0.53 ± 0.03* 0.51 ± 0.04 0.54 ± 0.04* 0.252 0.015 0.821 
CVC, ml min-1 mmHg-1 3.90 ± 0.38 4.05 ± 0.34* 4.07 ± 0.45 4.21 ± 0.52* 0.256 0.034 0.928 
Values are means ± standard deviation (SD). V
．
E, pulmonary ventilation, PETCO2, partial pressure of end-tidal carbon dioxide; HR, heart rate;        bpm, 
beats per minute; MAP, mean arterial pressure; SpO2, arterial oxygen saturation; CVC, cerebrovascular conductance; Suppl., supplementation.    * 
indicates a statistical difference between normoxia and hypoxia within the same supplementation. 
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Table 2. Hemodynamic responses to the thigh-cuff test in normoxia and hypoxia after placebo and nitrate supplementation. 
 Placebo Nitrate Two-way ANOVA 
 Normoxia Hypoxia Normoxia Hypoxia Suppl. Oxygen Interaction 
Thigh-cuff response                
Max. ΔMAP (%) -26.0 ± 4.1 -25.6 ± 4.6 -26.9 ± 3.8 -26.6 ± 3.8 0.525 0.683 0.913 
Max. ΔICA flow (%) -17.2 ± 2.3 -21.2 ± 4.7* -17.9 ± 2.7 -21.8 ± 3.3* 0.557 <0.001 0.987 
Dynamic CA variables (1-4 s after deflation)             
Slope of CVC 0.041 ± 0.006 0.023 ± 0.008* 0.040 ± 0.011 0.026 ± 0.004* 0.646 <0.001 0.345 
ΔMAP (%) -17.0 ± 3.0 -16.7 ± 5.3 -17.9 ± 3.5 -17.1 ± 3.4 0.631 0.591 0.804 
Values are mean ± SD. MAP, mean arterial pressure; ICA, internal carotid artery; CVC, cerebrovascular conductance; Suppl., supplementation. * 
indicate significant difference between normoxia and hypoxia within the same supplementation. 
 
 
